Pathophysiology of portal hypertension

Bailliere's Clinical Gastroenterology

Volumn 11, Issue 2, 1997, Pages 203-219

  Gupta, Tarun K ^a,b,c   Chen, Lisa ^a,b   Groszmann, Roberto J ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIDGEPORT HOSPITAL   (United States)

Author keywords

Hyperdynamic circulation; Intrahepatic resistance; Oesophageal varices; Pharmacotherapy; Plasma volume; Portal hypertension; Porto systemic collaterals; Variceal haemorrhage; Vasoconstrictors; Vasodilators

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN; VASOCONSTRICTOR AGENT;

BLOOD VESSEL TONE; CHRONIC LIVER DISEASE; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; HEART INDEX; PLASMA VOLUME; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; REVIEW; SPLANCHNIC BLOOD FLOW; VASCULAR RESISTANCE; VASODILATATION;

EID: 0030779779     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(97)90036-1     Document Type: Article

References (55)

1. Albillos A, Colombato LA & Groszmann RJ (1992) Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 102: 931-935.
2. Albillos A, Colombato LA, Lee FY et al (1993) Octreotide ameliorates vasodilatation and sodium retention in portal hypertensive rats. Gastroenterology 104: 575-579.
3. Baldus WP & Hoffbauer FW (1963) Vascular changes in the cirrhotic liver as studied by injection technique. American Journal of Digestive Disease 8: 689-692.
4. Beker S & Valencia-Parparcen J (1968) Portal hypertension syndrome. A comparative analysis of bilharzial fibrosis and hepatic cirrhosis. American Journal of Digestive Disease 13: 1047-1054.
5. Bhathal PS & Grossman HJ (1985) Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. Journal of Hepatology 1: 325-337.
6. Benoit JN, Barrowman JA, Harper SL et ai (1984) Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. American Journal of Physiology 247: G486-G493.
7. Brion E, Brenard R, Pariente EA et al (1991) Sinusoidal portal hypertension in hepatic amyloidosis. Gut 32: 227-230.
8. *Casadevall M, Panes J, Pique JM et al (1993) Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology 18: 628-634.
9. Claria J, Jimenez W, Ros J et al (1993) Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 15: 343-349.
10. *Colombato LA, Albillos A & Groszmann RJ (1992) Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology 15: 323-328.
11. Doni MG, Whittle BJ, Palmer RM et al (1988) Action of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. European Journal of Pharmacology 151: 19-25.
12. Garcia-Pagan JC, Fernandez M, Bernadich C et al (1994a) Effect of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. American Journal of Physiology 267: G984-G990.
13. Garcia-Pagan JC, Feu F, Castells A et al (1994b) Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis. Hepatology 19: 595-601.
14. *Garcia-Tsao G, Groszmann RJ, Fisher RL et al (1985) Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 5: 419-424.
15. *Genecin P & Groszmann RJ (1993) Portal hypertension. In Schiff E & Schiff L (eds) Diseases of the Liver, pp 935-973. Philadelphia: JB Lippincott Company.
16. Genecin P, & Groszmann RJ (1994) The biology of portal hypertension. In Arias IM et al (eds) The Liver: Biology and Pathobiology, 3rd edn, pp 1327-1341. Philadelphia: Lippincott-Raven.
17. Genecin P, Polio J & Groszmann RJ (1990a) Sodium restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension. American Journal of Physiology 259: G498-G503.
18. Genecin P, Polio J, Ferraioli G et al (1990b) Bile acids do not mediate the hyperdynamic circulation in portal hypertensive rats. American Journal of Physiology 259: G21-G25.
19. Gomis R, Fernandez-Alvarez J, Pizcueta Pet al (1994) Impaired function of pancreatic islets from rats with portal hypertension resulting from cirrhosis and partial portal vein ligation. Hepatology 19: 1257-1261.
20. Greenway CV & Stark RD (1971) Hepatic vascular bed. Physiological Review 51: 23-65.
21. Groszmann RJ & Atterbury CE (1982) The pathophysiology of portal hypertension. A basis for classification. Seminars in Liver Disease 2: 177-186.
22. Gupta TK & Groszmann RJ (1994) Administration of L-arginine, the physiological precursor of nitric oxide, reduces portal perfusion pressure and ameliorates hepatic vascular hyperreactivity in experimental cirrhosis. Hepatology 20(4): 200A.
23. Gupta TK, Chung M, Sessa WC et al (1995) Impaired endothelial function in the intrahepatic circulation in cirrhosis. Hepatology 22(4): 156A.
24. Halvorsen JF & Myking AO (1974) The portosystemic collateral pattern in the rat. European Surgical Research 6: 183-195.
25. Jensen JE and Groszmann RJ (1992) Complications of liver disease: pathophysiology and management. In Kaplowitz N (ed.) Liver and Biliary Diseases, pp 494-504. Baltimore: Williams & Wilkins.
26. Johnson SJ, Hines JE & Burt AD (1992) Phenotypic modulation of perisinusoidal cells following acute liver injury - a quantitative analysis. International Journal of Experimental Pathology 73: 765-772.
27. Karatapanis S, McCormick PA, Kakad S et al (1994) Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats. Hepatology 20: 1516-1521.
28. Lee F-Y, Colombato LA, Albillos A et al (1993a) Administration of N-omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 105: 1464-1470.
29. w-nitro-L-arginine administration corrects vasodilatation and systemic capillary hypotension, and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology 17: 84-90.
30. van Leeuwen DJ, Howe SC, Scheuer PJ, et al (1991) Portal hypertension in chronic hepatitis: relationship to morphological changes. Gut 31: 339-343.
31. Lieber CS, Zimmon DS, Kessler RE et al (1976) Portal hypertension in experimental alcoholic liver injury. Clinical Research 24: 478(a).
32. Liebermann FL & Reynolds TB (1967) Plasma volume in cirrhosis of the liver. Journal of Clinical Investigation 46: 1279-1308.
33. *Lopez-Talavera JC, Merrill WW & Groszmann RJ (1995) Tumor necrosis factor a: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 108: 761-767.
34. Lopez-Talavera JC, Cadelina GW, Olchowski J et al (1996) Thalidomide inhibits tumor necrosis factor-α, decreases nitric oxide synthesis and ameliorates the hyperdynamic circulatory syndrome in portal hypertensive rats. Hepatology 23(6): 1616-1621.
35. Mittal MK, Gupta TK, Lee FY et al (1994) Nitric oxide modulates vascular tone in normal rat liver. American Journal of Physiology 267: G416-G422.
36. Mosca P, Lee F-Y, Kaumann AJ et al (1992) Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. American Journal of Physiology 263: G544-G550.
37. Pinzani M, Failli P, Ruocco C et al (1992) Fat-storing cells as liver-specific pericytes-spatial dynamics of agonist-stimulated intracellular calcium transients. Journal of Clinical Investigation 90: 642-646.
38. Pizcueta P, Garcia-Pagan JC, Fernandez M et al (1991) Glucagon hinders the effects of somatostatin on portal hypertension. Gastroenterology 101: 1710-1715.
39. Pizcueta MP, Casamitjana R, Bosch J et al (1995) Decreased systemic vascular sensitivity to norepineprine in portal hypertensive rats: role of hyperglucagonemia. American Journal of Physiology 258: G191-G195.
40. *Polio J & Groszmann RJ (1986) Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Seminars of Liver Disease 6: 318-331.
41. Popper H & Zak FG (1958) Pathological aspects of cirrhosis. American Journal of Medicine 24: 593-625.
42. Reynolds TB, Hidmura R, Mitchell H et al (1969) Portal hypertension without cirrhosis in alcoholic liver disease. Annals of Internal Medicine 70: 497-506.
43. Rockey DC & Weisiger RA (1996) Endothelin induced contractility of stellate cell from normal and cirrhotic rat liver: implication for regulation of portal pressure and resistance. Hepatology 24(1): 233-240.
44. Rodriguez-Perez F, Isales CM & Groszmann RJ (1993) Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis. Gastroenterology 105: 863-867.
45. Rubanyi GM (1990) Endothelium-derived relaxing and contracting factors. Journal of Cellular Biochemistry 46: 27-36.
46. Rudolph R, McClure WJ & Woodward M (1979) Contractile fibroblasts in chronic alcoholic cirrhosis. Gastroenterology 76: 704-709.
47. Schaffner F & Popper H (1963) Capillarization of the hepatic sinusoids in man. Gastroenterology 44: 239-251.
48. *Sieber CC & Groszmann RJ (1992a) Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 103: 235-239.
49. Sieber CC & Groszmann RJ (1992b) In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade. American Journal of Physiology 262: G996-G1001.
50. Sikuler E & Groszmann RJ (1986) Hemodynamic studies in long- and short-term portal hypertensive rats: the relation of systemic glucagon levels. Hepatology 6(3): 414-418.
51. Sikuler E, Kravetz D & Groszmann RJ (1985) Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. American Journal of Physiology 248: G618-G625.
52. Sitzmann JV, Campbell KA, Wu Y et al (1993) Effect of portosystemic shunting on PGI, and glucagon levels in humans. Annals of Surgery 217: 248-252.
53. *Vallance P & Moncada S (1991) Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 337: 776-778.
54. Vane JR, Anggard EE & Botting RM (1990) Regulatory functions of vascular endothelium. New England Journal of Medicine 323: 27-36.
55. Wu Y, Burns C & Sitzmann JV (1993) Effects of nitric oxide and cyclooxygenase inhition on splanchnic hemodynamics in portal hypertension. Hepatology 18: 1416-1421.